New research from the Center for Disease Control and Prevention indicates that by early fall 2022, an overwhelming percentage of American adults had antibodies to SARS-CoV-2, the virus that causes COVID-19. According to the study, 96% of 72,748 blood donors aged 16 years and older included in the study had antibodies. Of that group, 23% acquired their immunity from infection alone and 26% from vaccination alone; 48% had hybrid immunity. Researchers say a low prevalence of infection-induced hybrid immunity among older adults reaffirms the importance of this group staying up to date on their vaccination and gaining easy access to antiviral treatments, since they are at increased risk of severe COVID-19. 
 

Related News Articles

Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…